Madrigal Pharmaceuticals Inc
MDGL
Market Cap$6.11B
Close$
$153.44
44.9% downside
Current Fair Value
44.9% downsideOvervalued by 44.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.11 Billion |
|---|---|
| Enterprise Value | $5.93 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-21.9 |
| Beta | -0.92 |
| Outstanding Shares | 22,091,314 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -15.53 |
|---|---|
| PEG | 30.83 |
| Price to Sales | 21.4 |
| Price to Book Ratio | 8.69 |
| Enterprise Value to Revenue | 19.58 |
| Enterprise Value to EBIT | -15.04 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Madrigal Pharmaceuticals Inc
CEO: Rebecca Taub